AstraZeneca PLC

    AZN ·NYSE ·Pharmaceutical Preparations ·Inc. in X0
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals. Values reported in .

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 1 transaction across 1 insider. Net: +20 shares, $3,249.

    Date Insider Role Action Shares Price Value
    2026-08-08 Sharma Mani See Remarks Buy +20 $160.57 $3,249

    Source: SEC Form 4 filings.

    Recent SEC filings

    • 2026-04-29 6-K Interim Report (Foreign)
    • 2026-04-28 6-K Interim Report (Foreign)
    • 2026-04-27 6-K Interim Report (Foreign)
    • 2026-04-23 6-K Interim Report (Foreign)
    • 2026-04-21 6-K Interim Report (Foreign)
    • 2026-04-20 6-K Interim Report (Foreign)
    • 2026-04-09 6-K Interim Report (Foreign)
    • 2026-04-02 6-K Interim Report (Foreign)
    • 2026-04-01 6-K Interim Report (Foreign)
    • 2026-03-31 6-K Interim Report (Foreign)
    • 2026-03-27 6-K Interim Report (Foreign)
    • 2026-03-20 6-K Interim Report (Foreign)
    • 2026-03-16 6-K Interim Report (Foreign)
    • 2026-03-10 6-K Interim Report (Foreign)
    • 2026-03-10 6-K Interim Report (Foreign)